Ferrosa Therapeutics
PrivateLast Round
Seed
Apr 23, 2026
Total Funding Raised
$3.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ferrosa Therapeutics is a biotechnology company developing a first-in-class bispecific antibody to treat anemia of inflammation across chronic kidney disease, autoimmune disease, and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ferrosa Therapeutics Comparables
Compare Ferrosa Therapeutics with similar companies based on industry and business-model similarity.
Ferrosa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 23, 2026 |
Ferrosa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forty51 Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
$4M round led by Forty51 Ventures
Ferrosa Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ferrosa Therapeutics's valuation, stock price, and market status.